Author:
Zhang Qingxia,Su Haofan,Li Boyu,Bai Xiangrong,Yan Suying,Li Xiaoling
Funder
key technology research and development program of shandong
beijing science and technology planning project
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference37 articles.
1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the american heart association. Circulation. 2019;139(10):e56–528.
2. The Writing Committee of the Report on Cardiovascular Health and Desease in China. Report on Cardiovascular Health and Disases in China 2019: an Updated Summary. Chinese Circulation Journal. 2020;35(9): 833–854.
3. Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet (London, England). 2019;394(10204):1145–58.
4. Xu YM. Study on the status and prognosis of secondary prevention in patients with coronary heart disease after PCI. Chinese Circulation Journal. 2015(z1):59–59.
5. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387(10022):957–67.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献